Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Cavan John T Create: Alert

All | News | Filings
Date FiledTypeDescription
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Cavan John T (CFO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 10,000 shares @ $2, valued at $20k
11/30/2020 4 Cavan John T (CFO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Bought 4,500 shares @ $1.62, valued at $7.3k
08/21/2020 4 Cavan John T (CFO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 160,000 options @ $3.72, valued at $595.2k
04/07/2020 4 Cavan John T (CFO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 215,000 options @ $1.63, valued at $350.5k
07/25/2019 4 Cavan John T (CFO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 5,820 options @ $3.24, valued at $18.9k
07/03/2018 4 Cavan John T (CFO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
Txns: Bought 15 convertible preferred @ $1000, valued at $15k
Bought 8,625 warrants @ $1.55, valued at $13.4k
01/05/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2017 4 Cavan John T (CFO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
Txns: Granted 15,000 options @ $0.58, valued at $8.7k
07/07/2017 4 Cavan John T (CFO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
Txns: Granted 46,726 shares @ $0
06/22/2017 4 Cavan John T (CFO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
Txns: Bought 20,000 shares @ $0.65, valued at $13k
08/29/2016 4 Cavan John T (CFO) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
04/20/2016 3 Cavan John T (CFO) has filed a Form 3 on ContraVir Pharmaceuticals, Inc.
10/22/2010 3 Cavan John T (VP & Chief Accounting Officer) has filed a Form 3 on Aegerion Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy